BCEIE › News › CARERATING

Management change

CARE Ratings Independent Director Jatindar Pal Singh Bajaj appointed

CARE Ratings (CARERATING) said Jatindar Pal Singh Bajaj, Independent Director, has been appointed. The company is valued at about ₹4,870 crore.

BCEIE News Desk · Published 29 Oct 2026, 08:41 pm IST · Filing received 29 Oct 2026, 08:25 pm IST

What happened

In a filing with the NSE on 29 October 2026 at 08:25 PM, CARE Ratings (CARERATING) said that Jatindar Pal Singh Bajaj, Independent Director, has been appointed.

From the filing: "CARE Ratings Limited has informed the Exchange regarding Appointment of Mr Jatindar Pal Singh Bajaj as Non- Executive Non- Independent Director of the company w.e.f."

Company snapshot

CARE Ratings is a small-cap company, with a market value of about ₹4,870 crore.

The stock last traded at ₹1,620.2, against a 52-week range of ₹1,392.7–₹1,838 (11.8% below the high).

Before this filing the shares had moved −1.0% over the month and −4.6% over three months. Average daily turnover over the last 20 sessions was about ₹7.27 crore.

Promoters held 0.00% at the end of Q1 FY27. Foreign institutions owned 23.41% and domestic institutions 31.58%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY269425.88.61
Q2 FY2613656.718.9
Q3 FY2611235.911.96
Q4 FY2613152.817.58
Q1 FY2711232.310.73

What history shows

This is not the company's first management change disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.

Market-wide, 4,059 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • The appointment of a successor and any change in strategy or guidance.
  • 29 October 2026: Board meeting — Financial Results/Dividend.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on CARE Ratings Limited